Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Global Prevalence of Chronic Kidney Disease – A Systematic Review and Meta-Analysis
Nathan R. Hill, Samuel Fatoba, Jason Oke, et al.
PLoS ONE (2016) Vol. 11, Iss. 7, pp. e0158765-e0158765
Open Access | Times Cited: 3374

Showing 1-25 of 3374 citing articles:

Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015
Mohammad H Forouzanfar, Lily Alexander, H Ross Anderson, et al.
The Lancet (2016) Vol. 388, Iss. 10053, pp. 1659-1724
Open Access | Times Cited: 7366
Management of Chronic Kidney Disease Patients in the Intensive Care Unit: Mixing Acute and Chronic Illness
Silvia De Rosa, Sara Samoni, Gianluca Villa, et al.
Blood Purification (2017) Vol. 43, Iss. 1-3, pp. 151-162
Open Access | Times Cited: 4884
Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
Boris Bikbov, Caroline Purcell, Andrew S. Levey, et al.
The Lancet (2020) Vol. 395, Iss. 10225, pp. 709-733
Open Access | Times Cited: 4790
Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
Jeffrey D Stanaway, Ashkan Afshin, Emmanuela Gakidou, et al.
The Lancet (2018) Vol. 392, Iss. 10159, pp. 1923-1994
Open Access | Times Cited: 4282
Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
Emmanuela Gakidou, Ashkan Afshin, Amanuel Alemu Abajobir, et al.
The Lancet (2017) Vol. 390, Iss. 10100, pp. 1345-1422
Open Access | Times Cited: 2150
Epidemiology of chronic kidney disease: an update 2022
Csaba P. Kövesdy
Kidney International Supplements (2022) Vol. 12, Iss. 1, pp. 7-11
Open Access | Times Cited: 1692
Cardiovascular Disease in Chronic Kidney Disease
Joachim Jankowski, Jürgen Floege, Danilo Fliser, et al.
Circulation (2021) Vol. 143, Iss. 11, pp. 1157-1172
Open Access | Times Cited: 1195
The Controversial Role of Human Gut Lachnospiraceae
Mirco Vacca, Giuseppe Celano, Francesco Maria Calabrese, et al.
Microorganisms (2020) Vol. 8, Iss. 4, pp. 573-573
Open Access | Times Cited: 1180
Analysis of the Global Burden of Disease study highlights the global, regional, and national trends of chronic kidney disease epidemiology from 1990 to 2016
Yan Xie, Benjamin Bowe, Ali H. Mokdad, et al.
Kidney International (2018) Vol. 94, Iss. 3, pp. 567-581
Open Access | Times Cited: 899
Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy
Adeera Levin, Marcello Tonelli, Joseph V. Bonventre, et al.
The Lancet (2017) Vol. 390, Iss. 10105, pp. 1888-1917
Open Access | Times Cited: 830
Prevalence and Disease Burden of Chronic Kidney Disease
Jicheng Lv, Luxia Zhang
Advances in experimental medicine and biology (2019), pp. 3-15
Closed Access | Times Cited: 823
Chronic kidney disease
Paola Romagnani, Giuseppe Remuzzi, Richard J. Glassock, et al.
Nature Reviews Disease Primers (2017) Vol. 3, Iss. 1
Open Access | Times Cited: 759
CKD in diabetes: diabetic kidney disease versus nondiabetic kidney disease
Hans‐Joachim Anders, Tobias B. Huber, Berend Isermann, et al.
Nature Reviews Nephrology (2018) Vol. 14, Iss. 6, pp. 361-377
Closed Access | Times Cited: 619
A single number for advocacy and communication—worldwide more than 850 million individuals have kidney diseases
Kitty J. Jager, Csaba P. Kövesdy, Robyn G. Langham, et al.
Kidney International (2019) Vol. 96, Iss. 5, pp. 1048-1050
Open Access | Times Cited: 572
Iron management in chronic kidney disease: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference
Iain C. Macdougall, Andreas J. Bircher, Kai‐Uwe Eckardt, et al.
Kidney International (2016) Vol. 89, Iss. 1, pp. 28-39
Open Access | Times Cited: 440
The global prevalence of latent tuberculosis: a systematic review and meta-analysis
Adam Cohen, Victor Næstholt Dahl, Thomas Schön, et al.
European Respiratory Journal (2019) Vol. 54, Iss. 3, pp. 1900655-1900655
Open Access | Times Cited: 428
Conducting proportional meta-analysis in different types of systematic reviews: a guide for synthesisers of evidence
Timothy Hugh Barker, Celina Borges Migliavaca, Cinara Stein, et al.
BMC Medical Research Methodology (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 416
Updated Cardiovascular Prevention Guideline of the Brazilian Society of Cardiology - 2019
Dalton Bertolim Précoma, Gláucia Maria Moraes de Oliveira, Antônio Felipe Simão, et al.
Arquivos Brasileiros de Cardiologia (2019)
Open Access | Times Cited: 362
Renal Subcapsular Transplantation of PSC-Derived Kidney Organoids Induces Neo-vasculogenesis and Significant Glomerular and Tubular Maturation In Vivo
Cathelijne W. van den Berg, Laila Ritsma, M. Cristina Avramut, et al.
Stem Cell Reports (2018) Vol. 10, Iss. 3, pp. 751-765
Open Access | Times Cited: 361
A single number for advocacy and communication—worldwide more than 850 million individuals have kidney diseases
Kitty J. Jager, Csaba P. Kövesdy, Robyn G. Langham, et al.
Nephrology Dialysis Transplantation (2019) Vol. 34, Iss. 11, pp. 1803-1805
Open Access | Times Cited: 351
NAFLD as a driver of chronic kidney disease
Christopher D. Byrne, Giovanni Targher
Journal of Hepatology (2020) Vol. 72, Iss. 4, pp. 785-801
Open Access | Times Cited: 348
Heart failure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
Andrew A. House, Christoph Wanner, Mark J. Sarnak, et al.
Kidney International (2019) Vol. 95, Iss. 6, pp. 1304-1317
Open Access | Times Cited: 321
Extracellular Matrix in Kidney Fibrosis: More Than Just a Scaffold
Roman D. Bülow, Peter Boor
Journal of Histochemistry & Cytochemistry (2019) Vol. 67, Iss. 9, pp. 643-661
Open Access | Times Cited: 294
Reducing the costs of chronic kidney disease while delivering quality health care: a call to action
Raymond Vanholder, Lieven Annemans, Edwina A. Brown, et al.
Nature Reviews Nephrology (2017) Vol. 13, Iss. 7, pp. 393-409
Closed Access | Times Cited: 285
CKD: A Call for an Age-Adapted Definition
Pierre Delanaye, Kitty J. Jager, Arend Bökenkamp, et al.
Journal of the American Society of Nephrology (2019) Vol. 30, Iss. 10, pp. 1785-1805
Open Access | Times Cited: 284
Page 1 - Next Page

Scroll to top